David Liebeskind, MD
Enriched profileCo-Director, USC Neurovascular Center; Visiting Professor of Neurology, Neurological Surgery and Radiology, Keck School of Medicine of USC · University of Southern California
David Liebeskind is Co-Director, USC Neurovascular Center; Visiting Professor of Neurology, Neurological Surgery and Radiology, Keck School of Medicine of USC at University of Southern California. OpenAlex indexes 1,685 publications with 62,202 citations (h-index 113); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Liebeskind, MD, is Co-Director, USC Neurovascular Center at University of Southern California, Keck School of Medicine (USC Neurovascular Center). The public record shows 1,685 publications with 62,202 citations (h-index 113), centered on Stroke. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 20 companies, 12 NIH-funded awards (2006–2026).
- Most recent indexed publication: 2026 · Journal of neurointerventional surgery
- Top research focus: Stroke
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 20 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 134 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Co-author
"Neurovascular Innovation at the FDA: Pivotal Strategies to Effectively Modernize the Realization of Diagnostic, Drug, and Device Products" …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ahajournals.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Sponsor: University of California, Los Angeles
- Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke
Sponsor: University of California, Los Angeles
Industry payments
Updated 27 Aug 2026
20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Medical Device Business Services, Inc.Program year202562 payments$379,978openpaymentsdata.cms.gov ↗
- Balt USA, LLCProgram year20252 payments
- Olea MedicalProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
52.8%P2Y12 inhibitor32.4%Clopidogrel100%Part D≥20 patientsFactor Xa inhibitor20.4%Eliquis100%Part D<11 patientsCardiovascular
47.2%Statin47.2%Atorvastatin Calcium100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
12 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Platelet Expression of FcgammaRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
University of Southern California
FY2026$759,519R01NS123734
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Faster reperfusion with combined delivery catheter systems in aspiration-first stroke thrombectomy: a multicenter analysis.
Journal of neurointerventional surgery
Article2026 - Territorial Stroke in SAMMPRIS: Critical Analyses of Stroke Prevention in Intracranial Atherosclerosis.
Stroke (Hoboken, N.J.)
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-liebeskind-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/david-liebeskind
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/dliebesk
Mentions by others
where others cite or feature them- Other
keck.usc.edu/news/dr-david-liebeskind-delivers-neurology-grand-rounds
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keck.usc.edu ↗ - LinkedIn
LinkedIn: David S Liebeskind, MD, MBA, University of Southern California
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
X/Twitter handle @dliebesk (David S Liebeskind, MD, MBA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicine.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicine.usc.edu ↗
- Board Certified in Neurology
American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicine.usc.edu ↗
Editorial & leadership roles
journal and society appointments- Co-Director / Co-Founder
USC Neurovascular Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicine.usc.edu ↗ - Past President
Society of Vascular and Interventional Neurology (SVIN), first vascular neurologist and only non-interventionist to hold the role
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuronewsinternational.com ↗ - Past President
American Society of Neuroimaging
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuronewsinternational.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →svin.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicine.usc.edu ↗
- Fellow
American Heart Association (FAHA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuronewsinternational.com ↗
Secondary affiliations
appointments beyond the home institution- Prior: Professor of Neurology; Director of Stroke Imaging and Neurovascular Research Programs
UCLA David Geffen School of Medicine
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuronewsinternational.com ↗ - Founder & CEO
Brainstorme (cloud-based neuroimaging core-lab platform)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuronewsinternational.com ↗
Media & interviews
press, podcasts and appearances- "Meet David S. Liebeskind, MD, MBA"
Keck Medicine of USC blog feature on his move to USC and clinical/educational philosophy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗ - "PROFILE: David Liebeskind"
feature profile in NeuroNews International covering his career, entrepreneurship (Brainstorme), and SVIN leadership
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neuronewsinternational.com ↗ - "Dr. David Liebeskind Delivers Neurology Grand Rounds"
Keck School of Medicine news item on an invited lecture, "The Role of Collaterals in Determining Fast and Slow Progressors" (predates his USC faculty appointment …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keck.usc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
Rohit Varma, MD
University of Southern California